Page 41 - Evelop News Today

CD3 antibody has emerged as an established and attractive target for Type 1 diabetes after the $2.9 billion acquisition of Provention Bio by SanofiMechanism of Action of Tiziana's first-in-class, only

A historic San Francisco hotel that's nestled atop famed Nob Hill was bought for a fraction of the property's assessed value.

Objectives: To develop innovative solutions for timber construction, in particular for timber-frame facades. These solutions will integrate optimised... | April 18, 2023

Paris, 18 April 2023 - PT PLN (Persero) signed a Memorandum of Understanding (MoU) with Hydrogen de France SA (HDF Energy) to develop hydrogen technology in Indonesia. This international collaboration

NEW YORK, April 17, 2023 -- Cellectis , a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today released preclinical... | April 17, 2023

At the MODAL research campus, mathematicians from academia and FICO develop new algorithms to solve pressing business problems. Practical insights into the lively exchange between science and... | April 17, 2023

Partnership Focuses on Delivering Fully Digital-Enabled Edge Terminal Solutions SAN DIEGO and READING, United Kingdom, April 17, 2023 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (Nasdaq:

By Stephen Nakrosis Avangrid and the Navajo Tribal Utility Authority on Monday said they signed a Memorandum of Understanding and will explore opportunities to develop green energy projects.... | April 17, 2023

BOSTON, April 17, 2023 /PRNewswire/ -- Sapphiros, a platform company dedicated to building the next generation of consumer diagnostic technologies, is proud to announce it has been selected

The luxury boutique hotel will open by Q4 2023 with 35 guest rooms RCU names GHM to operate the hotel under The Chedi brandRCU is carefully uplifting several existing heritage buildings, including